Purinergic signalling: From discovery to current developments

Experimental Physiology

Volumn 99, Issue 1, 2014, Pages 16-34

  Burnstock, Geoffrey ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ECTO 5' NUCLEOTIDASE; GROWTH FACTOR; NEUROTRANSMITTER; NORADRENALIN; PURINERGIC P2 RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC RECEPTOR;

ARTICLE; CENTRAL NERVOUS SYSTEM; EXCITATORY JUNCTION POTENTIAL; HUMAN; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; MECHANICAL STIMULATION; MECHANOTRANSDUCTION; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE REGENERATION; NERVE STIMULATION; NEUROMODULATION; NEUROMUSCULAR TRANSMISSION; NEUROTRANSMISSION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PARASYMPATHETIC NERVE; PATHOPHYSIOLOGY; PURINERGIC SIGNALING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STIMULUS RESPONSE; SYMPATHETIC NERVE; SYNAPTIC TRANSMISSION; THROMBOCYTE ACTIVATION; VAS DEFERENS;

ADENOSINE TRIPHOSPHATE; ANIMALS; HUMANS; PURINERGIC AGENTS; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 84891107456     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2013.071951     Document Type: Article

References (101)

1. 2Y purinoceptors Pharmacol Ther 64, 445-475.
2. Abbracchio MP & Burnstock G (1998). Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 78, 113-145.
3. Agboh KC, Webb TE, Evans RJ & Ennion SJ (2004). Functional characterization of a P2X receptor from Schistosoma mansoni. J Biol Chem 279, 41650-41657.
4. Abbracchio MP, Burnstock G, Verkhratsky A & Zimmermann H (2009). Purinergic signalling in the nervous system: an overview. Trends Neurosci 32, 19-29.
5. Bailey MA, Shirley DG, King BF, Burnstock G & Unwin RJ (2007). Extracellular nucleotides and renal function. In The Kidney: Physiology and Pathophysiology, ed. Alpern RJ & Herbert SCG, pp. 425-443. Elsevier, San Diego.
6. Baqi Y, Lee SY, Iqbal J, Ripphausen P, Lehr A, Scheiff AB, Zimmermann H, Bajorath J & Müller CE (2010). Development of potent and selective inhibitors of ecto-5′-nucleotidase based on an anthraquinone scaffold. J Med Chem 53, 2076-2086.
7. Bodin P & Burnstock G (2001). Purinergic signalling: ATP release. Neurochem Res 26, 959-969.
8. Brake AJ, Wagenbach MJ & Julius D (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371, 519-523.
9. Burnstock G (1958a). The effects of acetylcholine on membrane potential, spike frequency, conduction velocity and excitability in the taenia coli of the guinea-pig. J Physiol 143, 165-182.
10. Burnstock G (1958b). The action of adrenaline on excitability and membrane potential in the taenia coli of the guinea-pig and the effect of DNP on this action and on the action of acetylcholine. J Physiol 143, 183-194.
11. Burnstock G (1972). Purinergic nerves. Pharmacol Rev 24, 509-581.
12. Burnstock G (1976). Do some nerve cells release more than one transmitter Neuroscience 1, 239-248.
13. Burnstock G (1978). A basis for distinguishing two types of purinergic receptor. In Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach, ed. Straub RW & Bolis L, pp. 107-118. Raven Press, New York.
14. Burnstock G (1986). The changing face of autonomic neurotransmission. [The first von Euler Lecture in Physiology.] Acta Physiol Scand 126, 67-91.
15. Burnstock G (1987). Local control of blood pressure by purines. Blood Vessels 24, 156-160.
16. Burnstock G (1990). Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem Int 17, 357-368.
17. Burnstock G (1996a). A unifying purinergic hypothesis for the initiation of pain. Lancet 347, 1604-1605.
18. Burnstock G (1996b). P2 Purinoceptors: historical perspective and classification. In P2 Purinoceptors: Localization, Function and Transduction Mechanisms. Ciba Foundation Symposium, vol. 198, ed. Chadwick DJ & Goode JA, pp. 1-29. John Wiley and Sons, Chichester.
19. Burnstock G (1999). Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194, 335-342.
20. Burnstock G (2001). Expanding field of purinergic signaling. Drug Dev Res 52, 1-10.
21. Burnstock G (2002). Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22, 364-373.
22. Burnstock G (2003). Introduction: ATP and its metabolites as potent extracellular agonists. In Current Topics in Membranes, vol. 54, Purinergic Receptors and Signalling, ed. Schwiebert EM, pp. 1-27. Academic Press, San Diego.
23. Burnstock G (2004). A moment of excitement. Living History Series. The discovery of non-adrenergic, non-cholinergic neurotransmission. Physiol News 56, 7-9.
24. Burnstock G (2007a). Purine and pyrimidine receptors. Cell Mol Life Sci 64, 1471-1483.
25. Burnstock G (2007b). Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87, 659-797.
26. Burnstock G (2008a). Purinergic signalling in atherosclerosis and restenosis. IAS website http://www.athero.org/commentaries/comm770.pdf.
27. Burnstock G (2008b). Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7, 575-590.
28. Burnstock G (2009a). Acupuncture: a novel hypothesis for the involvement of purinergic signalling. Med Hypotheses 73, 470-472.
29. Burnstock G (2009b). Purinergic mechanosensory transduction and visceral pain. Mol Pain 5, 69.
30. Burnstock G (2009c). Cotransmission. In Encyclopedia of Neuroscience, ed. Squire LR, pp. 247-254. Academic Press, Oxford.
31. Burnstock G (2011). Therapeutic potential of purinergic signalling for diseases of the urinary tract. BJU Int 107, 192-204.
32. Burnstock G (2012a). Purinergic signalling: its unpopular beginning, its acceptance and its exciting future. Bioessays 34, 218-225.
33. Burnstock G (2012b). Targeting the visceral purinergic system for pain control. Curr Opin Pharmacol 12, 80-86.
34. Burnstock G (2012c). Cotransmission. In Primer of the Autonomic Nervous System, 3rd edition, ed. Robertson D, Biaggioni I, Burnstock G, Low P & Paton JF, pp. 27-34. Academic Press, Oxford.
35. Burnstock G, Campbell G, Bennett M & Holman ME (1964). Innervation of the guinea-pig taenia coli: are there intrinsic inhibitory nerves which are distinct from sympathetic nerves Int J Neuropharmacol 3, 163-166.
36. Burnstock G, Campbell G & Rand MJ (1966). The inhibitory innervation of the taenia of the guinea-pig caecum. J Physiol 182, 504-526.
37. Burnstock G, Campbell G, Satchell D & Smythe A (1970). Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40, 668-688.
38. Burnstock G, Cocks T, Crowe R & Kasakov L (1978). Purinergic innervation of the guinea-pig urinary bladder. Br J Pharmacol 63, 125-138.
39. Burnstock G & Costa M (1975). Adrenergic Neurones: Their Organisation, Function and Development in the Peripheral Nervous System. pp. 1-225. Chapman and Hall, London.
40. Burnstock G & Di Virgilio F (2013). Purinergic signalling in cancer. Purinergic Signal [Epub ahead of print 25/6/13]. DOI 10.1007/s11302-013-9372-5
41. Burnstock G, Fredholm BB, North RA & Verkhratsky A (2010). The birth and postnatal development of purinergic signalling. Acta Physiol (Oxf) 199, 93-147.
42. Burnstock G & Holman ME (1960). Autonomic nerve-smooth muscle transmission. Nature 187, 951-952.
43. Burnstock G & Holman ME (1961). The transmission of excitation from autonomic nerve to smooth muscle. J Physiol 155, 115-133.
44. 2-purinoceptor Gen Pharmacol 16, 433-440.
45. Burnstock G & Kennedy C (2011). P2X receptors in health and disease. In Purine and Pyrimidine Receptor Pharmacology, ed. Jacobson KA & Linden J, pp. 333-372. Academic Press, Burlington.
46. Burnstock G, Krügel U, Abbracchio MP & Illes P (2011). Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol 95, 229-274.
47. Burnstock G & Straub RW (1958). A method for studying the effects of ions and drugs on the resting and action potentials in smooth muscle with external electrodes. J Physiol 140, 156-167.
48. Burnstock G & Ulrich H (2011). Purinergic signalling in embryonic and stem cell development. Cell Mol Life Sci 68, 1369-1394.
49. Burnstock G & Verkhratsky A (2009). Evolutionary origins of the purinergic signalling system. Acta Physiol (Oxf) 195, 415-447.
50. Burnstock G & Verkhratsky A (2010). Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis 1, e9.
51. Burnstock G & Verkhratsky A (2012). Purinergic Signalling and the Nervous System, Springer, Heidelberg /Berlin.
52. Burnstock G & Wong H (1978). Comparison of the effects of ultraviolet light and purinergic nerve stimulation on the guinea-pig taenia coli. Br J Pharmacol 62, 293-302.
53. Clark G & Roux SJ (2009). Extracellular nucleotides: ancient signaling molecules. Plant Sci 177, 239-244.
54. Daly JW (1985). Adenosine receptors. Adv Cyclic Nucleotide Protein Phosphorylation Res 19, 29-46.
55. Demidchik V, Nichols C, Oliynyk M, Dark A, Glover BJ & Davies JM (2003). Is ATP a signaling agent in plants Plant Physiol 133, 456-461.
56. Demidchik V, Shang Z, Shin R, Colaco R, Laohavisit A, Shabala S & Davies JM (2011). Receptor-like activity evoked by extracellular ADP in Arabidopsis root epidermal plasma membrane. Plant Physiol 156, 1375-1385.
57. Drury AN & Szent-Györgyi A (1929). The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol 68, 213-237.
58. Edwards FA, Gibb AJ & Colquhoun D (1992). ATP receptor-mediated synaptic currents in the central nervous system. Nature 359, 144-147.
59. Erlinge D & Burnstock G (2008). P2 receptors in cardiovascular physiology and disease. Purinergic Signal 4, 1-20.
60. Evans RJ, Derkach V & Surprenant A (1992). ATP mediates fast synaptic transmission in mammalian neurons. Nature 357, 503-505.
61. Fountain SJ & Burnstock G (2009). An evolutionary history of P2X receptors. Purinergic Signal 5, 269-272.
62. Fountain SJ, Cao L, Young MT & North RA (2008). Permeation properties of a P2X receptor in the green algae Ostreococcus tauri. J Biol Chem 283, 15122-15126.
63. Fountain SJ, Parkinson K, Young MT, Cao L, Thompson CR & North RA (2007). An intracellular P2X receptor required for osmoregulation in Dictyostelium discoideum. Nature 448, 200-203.
64. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN & Linden J (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53, 527-552.
65. Gachet C (2006). Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46, 277-300.
66. Gever JR, Rothschild S, Henningsen R, Martin R, Hackos D, Panicker S, Rubas W, Oglesby I, Dillon MP, Milla ME, Burnstock G & Ford APDW (2010). AF-353, a novel, potent orally bioavailable P2X3/P2X2/3 receptor antagonist. Br J Pharmacol 160, 1387-1398.
67. Glass R, Bardini M, Robson T & Burnstock G (2001). Expression of nucleotide P2X receptor subtypes during spermatogenesis in the adult rat testis. Cells Tissues Organs 169, 377-387.
68. Guarnieri S, Fanò G, Rathbone MP & Mariggiò MA (2004). Cooperation in signal transduction of extracellular guanosine 5′ triphosphate and nerve growth factor in neuronal differentiation of PC12 cells. Neuroscience 128, 697-712.
69. Holton P (1959). The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol 145, 494-504.
70. Höpker VH, Saffrey MJ & Burnstock G (1996). Neurite outgrowth of striatal neurons in vitro: involvement of purines in the growth promoting effect of myenteric plexus explants. Int J Dev Neurosci 14, 439-451.
71. 2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol 86, 291-294.
72. 4 ion channel in the closed state. Nature 460, 592-598.
73. Kim SY, Sivaguru M & Stacey G (2006). Extracellular ATP in plants. Visualization, localization, and analysis of physiological significance in growth and signaling. Plant Physiol 142, 984-992.
74. Kunapuli SP & Daniel JL (1998). P2 receptor subtypes in the cardiovascular system. Biochem J 336, 513-523.
75. Lazarowski ER (2012). Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 8, 359-373.
76. Lazarowski ER, Sesma JI, Seminario-Vidal L & Kreda SM (2011). Molecular mechanisms of purine and pyrimidine nucleotide release. Adv Pharmacol 61, 221-261.
77. Lustig KD, Shiau AK, Brake AJ & Julius D (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci U S A 90, 5113-5117.
78. Neary JT & Zimmermann H (2009). Trophic functions of nucleotides in the central nervous system. Trends Neurosci 32, 189-198.
79. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J 17, 3016-3028.
80. North RA (1996). P2X purinoceptor plethora. Semin Neurosci 8, 187-195.
81. North RA (2002). Molecular physiology of P2X receptors. Physiol Rev 82, 1013-1067.
82. Orriss IR, Burnstock G & Arnett TR (2010). Purinergic signalling and bone remodelling. Curr Op Pharmacol 10, 322-330.
83. Paton WD & Vane JR (1963). Analysis of the responses of the isolated stomach to electrical stimulation and to drugs. J Physiol 165, 10-46.
84. Rapaport E (1983). Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J Cell Physiol 114, 279-283.
85. Rossato M, La Sala GB, Balasini M, Taricco F, Galeazzi C, Ferlin A & Foresta C (1999). Sperm treatment with extracellular ATP increases fertilization rates in in-vitro fertilization for male factor infertility. Hum Reprod 14, 694-697.
86. Shabbir M & Burnstock G (2009). Purinergic receptor-mediated effects of adenosine 5′-triphosphate in urological malignant diseases. Int J Urol 16, 143-150.
87. Shabbir M, Thompson CS, Jarmulowicz M, Mikhailidis DP & Burnstock G (2008). Effect of extracellular ATP on the growth of hormone refractory prostate cancer in vivo. BJU Int 102, 108-112.
88. Silinsky EM, Gerzanich V & Vanner SM (1992). ATP mediates excitatory synaptic transmission in mammalian neurones. Br J Pharmacol 106, 762-763.
89. Sneddon P & Burnstock G (1984). Inhibition of excitatory junction potentials in guinea-pig vas deferens by α, β-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur J Pharmacol 100, 85-90.
90. 3H]Adenosine triphosphate: release during stimulation of enteric nerves. Science 173, 337-339.
91. 7-deficiency ameliorates accelerated nephrotoxic nephritis in mice. J Am Soc Nephrol 20, 1275-1281.
92. Tew EMM, Anderson PN, Saffrey MJ & Burnstock G (1994). Transplantation of the postnatal rat myenteric plexus into the adult rat corpus striatum: an electron microscopic study. Exp Neurol 129, 120-129.
93. Tew EMM, Saffrey MJ, Anderson PN & Burnstock G (1996). NADPH-diaphorase containing enteric neurones survive for a year in the adult rat striatum. Neuroreport 7, 958-960.
94. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S & Inoue K (2004). Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45, 89-95.
95. Ulrich H, Abbracchio MP & Burnstock G (2012). Extrinsic purinergic regulation of neural stem/progenitor cells: implications for CNS development and repair. Stem Cell Rev 8, 755-767.
96. 2X receptor for extra-cellular ATP. Nature 371, 516-519.
97. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G & Barnard EA (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 324, 219-225.
98. White N & Burnstock G (2006). P2 receptors and cancer. Trends Pharmacol Sci 27, 211-217.
99. Yegutkin GG (2008). Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783, 673-694.
100. Zimmermann H (2001). Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 52, 44-56.
101. Zimmermann H (2006). Nucleotide signaling in nervous system development. Pflugers Arch 452, 573-588.